Company Filing History:
Years Active: 2006-2021
Title: The Innovative Contributions of Mei-Mei Tsai
Introduction
Mei-Mei Tsai is a prominent inventor based in Thousand Oaks, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. With a total of 16 patents to her name, Tsai's work has the potential to impact the treatment of various pathological conditions.
Latest Patents
One of her latest patents is focused on dual receptor antagonistic antigen-binding proteins and their uses. This disclosure relates to antagonistic dual receptor antigen-binding proteins, such as antibodies, and methods for using these dual receptor antibodies in the treatment of pathological diseases. The dual receptor antibodies may include an antibody to ActRII receptors, which can be utilized to treat conditions such as muscle wasting diseases or any disease that necessitates stimulation of muscle growth.
Career Highlights
Mei-Mei Tsai is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. Her work at Amgen has allowed her to further her research and development efforts in the field of therapeutic proteins.
Collaborations
Throughout her career, Tsai has collaborated with notable colleagues, including Rajendra V Deshpande and Frank J Calzone. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Mei-Mei Tsai's innovative work in the field of biotechnology, particularly her advancements in dual receptor antagonistic antigen-binding proteins, showcases her dedication to improving therapeutic options for patients. Her contributions continue to pave the way for future innovations in medical treatments.